Deferasirox Tablet, For Suspension
Product Images NDC 69539-022
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 69539-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Msn Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig-01 (Deferasirox Figure 1)
125mg-30s (Deferasirox 125mg 30s Count)
125mg-90s (Deferasirox 125mg 90s Count)
125mg-1000s (Deferasirox 125mg 1000s Count)
10s-blister-foil (125mg 10s Blister Foil)
125mg-blister-carton (125mg 100s Blister Carton)
250mg-30s (Deferasirox 250mg 30s Count)
250mg-90s (Deferasirox 250mg 90s Count)
250mg-1000s (Deferasirox 250mg 1000s Count)
250mg-10s-blster-foil (250mg 10s Blister Foil)
250mg-blister-carton (250mg 100s Blister Carton)
500mg-30s (Deferasirox 500mg 30s Count)
500mg-90s (Deferasirox 500mg 90s Count)
500mg-500s (Deferasirox 500mg 500s Count)
500mg-10s-blstr-foil (500mg 10s Blister Foil)
500mg-blister-carton (500mg 100s Blister Carton Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.